Literature DB >> 12655342

HCV and interferon: viral strategies for evading innate defence mechanisms in the virus-host battle.

M R Capobianchi1, I Abbate, G Cappiello, M Solmone.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12655342     DOI: 10.1038/sj.cdd.4401142

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  4 in total

1.  Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.

Authors:  Lan-Juan Zhao; Xian Hua; Sheng-Fei He; Hao Ren; Zhong-Tian Qi
Journal:  Virol J       Date:  2011-04-06       Impact factor: 4.099

Review 2.  Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Authors:  Fabrizio Poccia; Chiara Agrati; Federico Martini; Gloria Mejia; Marianne Wallace; Miroslav Malkovsky
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

3.  Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.

Authors:  Chiara Agrati; Tonino Alonzi; Rafaella De Santis; Concetta Castilletti; Isabella Abbate; Maria Rosaria Capobianchi; Gianpiero D'Offizi; Francesca Siepi; Gian Maria Fimia; Marco Tripodi; Fabrizio Poccia
Journal:  Int Immunol       Date:  2005-12-16       Impact factor: 4.823

4.  Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy.

Authors:  Kei Miyakawa; Satoko Matsunaga; Koichi Watashi; Masaya Sugiyama; Hirokazu Kimura; Naoki Yamamoto; Masashi Mizokami; Takaji Wakita; Akihide Ryo
Journal:  Oncotarget       Date:  2015-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.